ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.
Erratum issued Registry-linked trialOpen access · bronzeAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06129201 (Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging), which is not on this map. Cited by 47 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging: a Prospective Multicenter Cross-sectional Study
Who cites it
47 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.
- Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020Pooled it
- A high-throughput Epstein-Barr virus nuclear antigen 1 (EBNA1) serology test strip for nasopharyngeal carcinoma risk screening.medRxiv : the preprint server for health sciences · 2026Article
- Anti-BNLF2b antibody for accurate diagnosis of nasopharyngeal carcinoma: a prospective comparative study.BMC cancer · 2026Article
- Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts.Blood cancer journal · 2026Article
- Anti-Epstein-Barr virus (EBV) antibodies in EBV-associated gastric carcinoma.Infectious agents and cancer · 2026Article
- Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma.The Journal of infectious diseases · 2026Article
- Proteome-Wide Serological Profiling Reveals Broad Elevation of EBV Immunity in Idiopathic Pulmonary Fibrosis.International journal of molecular sciences · 2026Article
- A novel multiplex approach for the comprehensive analysis of the Epstein-Barr virus-specific humoral immune response.Frontiers in cellular and infection microbiology · 2026Article
- Sex Differences in Anti-Epstein-Barr Virus Antibody Responses.The Journal of infectious diseases · 2025Article
- Herpesvirus-associated diseases: biomarkers and advancements in clinical research.Virology journal · 2025Review
- Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.Blood advances · 2025Article
- High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma.The Journal of clinical investigation · 2025Article
- Combined application of BNLF2b antibody with VCA-IgA, Rta-IgG, and Zta-IgA in nasopharyngeal carcinoma screening in the Guangxi region.PloS one · 2025Article
- Structures of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus virions reveal species-specific tegument and envelope features.Journal of virology · 2024Article
- The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024Article
- A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.International journal of cancer · 2024Article
- Epidemiology of nasopharyngeal carcinoma: current insights and future outlook.Cancer metastasis reviews · 2024Review
- Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.International journal of epidemiology · 2024Article
- Nasopharyngeal cancer screening with an anti-BNLF2b antibody: a new arrow in the quiver?Nature reviews. Clinical oncology · 2024Article
- Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
19 authors at 1 institution in 1 country.
Anna E CoghillDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. anna.coghill@nih.gov denise.doolan@jcu.edu.au.
Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Carla ProiettiQueensland Institute of Medical Research, Brisbane, Australia.
Wan-Lun HsuGenomics Research Center, Academica Sinica, Taipei, Taiwan.
Yin-Chu ChienGenomics Research Center, Academica Sinica, Taipei, Taiwan.
Lea LekieffreQueensland Institute of Medical Research, Brisbane, Australia.
Lutz KrauseQueensland Institute of Medical Research, Brisbane, Australia.
Andy TengAntigen Discovery Inc., Irvine, California.
Jocelyn PabloAntigen Discovery Inc., Irvine, California.
Kelly J YuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Pei-Jen LouDepartment of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Cheng-Ping WangDepartment of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Zhiwei LiuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Chien-Jen ChenGenomics Research Center, Academica Sinica, Taipei, Taiwan.
Jaap MiddeldorpVrije University Medical Center, Amsterdam, the Netherlands.
Jason MulvennaQueensland Institute of Medical Research, Brisbane, Australia.
Jeff BethonyDepartment of Microbiology, Immunology, and Tropical Medicine, George Washington University Medical Center, Washington, District of Columbia.
Allan Hildesheim *Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Denise L Doolan *Queensland Institute of Medical Research, Brisbane, Australia. anna.coghill@nih.gov denise.doolan@jcu.edu.au.
QIMR Berghofer Medical Research Institute · AU
Funding
Intramural NIH HHS Z99 CA999999
Abstract
PubMed holds no abstract for this paper.
Indexed as
Early Detection of CancerAdultAgedAntibodies, ViralCase-Control StudiesCross-Sectional StudiesEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHumansImmunoglobulin AImmunoglobulin GMaleMass ScreeningMiddle AgedNasopharyngeal CarcinomaAntibodies, ViralImmunoglobulin AImmunoglobulin G
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT06129201ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.